The Miami Entrepreneur

Dow Jones Newswires: Novartis posts lower sales and profit on generic competition, but boosts 2022 dividend

Read Time:9 Second

The Swiss pharma major posted net profit of $1.47 billion, down from $16.31 billion the year prior, when it benefited from the sale of its investment in Roche Holding.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Dow Jones Newswires: Novo Nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts
Next post Missing radioactive capsule found in Australia